Children's Health Defense By
Attorneys and human papillomavirus (HPV) vaccine experts Mary Holland and Michael Baum join “The Defender In-Depth” podcast to discuss the latest news — and known risks — associated with Merck’s Gardasil vaccine.
A new marketing campaign is promoting the Gardasil human papillomavirus (HPV) vaccine for teenagers and young adults — despite risks to human health, a high rate of adverse events and hundreds of ongoing lawsuits against its manufacturer, Merck.
“It was pretty clear right from the get-go that [Gardasil] was causing severe injuries,” said Mary Holland, president of Children’s Health Defense and co-author of “The HPV Vaccine on Trial: Seeking Justice for a Generation.”
Holland joined attorney Michael Baum of Los Angeles-based law firm Wisner Baum on this week’s “Defender In-Depth” podcast to discuss the risks of Gardasil, the lawsuits against Merck, and the new and “extreme” marketing campaign promoting the vaccine.
FDA approval of Gardasil ‘outrageous’
Holland and Baum said the risks of Gardasil were already apparent during its clinical trials, but the U.S. Food and Drug Association (FDA) issued an approval anyway.
“The clinical trials [for Gardasil] showed significant risks with this vaccine,” Holland said, noting that the trials showed that “for women who already had cervical infections or had antibodies to these viruses in their system … they were at higher risk for developing abnormal lesions of the cervix or worse, meaning cancer.”
“In their own clinical trials, Merck showed [a] 46% increased rate of those bad lesions, … occurred among girls who had an active HPV infection at the time,” Baum said…
READ FULL ARTICLE HERE… (childrenshealthdefense.org)
Home | Caravan to Midnight (zutalk.com)
